Medicare Enrolled
Dr. Jatinder Grewall, M.D.
Urology Physician · Fresno, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Grewall from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Grewall?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Grewall
Dr. Jatinder Grewall is an urology physician in Fresno, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Grewall performed 18,889 Medicare services across 3,871 unique beneficiaries.
Between the years covered by Open Payments, Dr. Grewall received a total of $12,984 from 50 pharmaceutical and/or device companies across 308 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Grewall is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 7% volume in CA
$12,984 industry payments
Medicare Practice Summary
Medicare Utilization ↗18,889
Medicare services
Top 7% in CA for urology physician
3,871
Unique beneficiaries
$28
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,049 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 7,740 | $18 | $40 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
2,900 | $0 | $0 |
| Injection, degarelix, 1 mg | 2,240 | $3 | $8 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,149 | $2 | $6 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,077 | $99 | $270 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
881 | $9 | $66 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
757 | $66 | $190 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
442 | $8 | $8 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 295 | $134 | $458 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
167 | $11 | $44 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
144 | $124 | $350 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
130 | $29 | $75 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
122 | $202 | $523 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
107 | $90 | $197 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
66 | $24 | $58 |
| X-ray of body plane An X-ray imaging test that captures a specific plane or section of the body to visualize internal structures. |
64 | $74 | $196 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
58 | $143 | $375 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
53 | $89 | $245 |
| Injection, tobramycin sulfate, up to 80 mg | 50 | $2 | $12 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
43 | $46 | $137 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
42 | $113 | $400 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
40 | $0 | $2 |
| Cell examination of specimen, concentration technique A laboratory test that uses a concentration technique to examine cells from a specimen. |
36 | $34 | $135 |
| Prostate needle biopsy pathology exam Laboratory examination of prostate tissue samples obtained via needle biopsy. The pathologist inspects the tissue both visually and under a microscope to identify any abnormalities. |
34 | $159 | $800 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
28 | $188 | $532 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
28 | $301 | $760 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
26 | $40 | $120 |
| 3D radiographic procedure with computerized image postprocessing A radiographic imaging procedure that creates three-dimensional images using computerized processing of the captured data. |
25 | $62 | $169 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
24 | $3 | $8 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
21 | $6 | $45 |
| Injection of biodegradable material next to prostate A procedure involving the injection of a biodegradable substance into the tissue surrounding the prostate gland. |
19 | $2,523 | $8,000 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
16 | $303 | $805 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
15 | $135 | $848 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
14 | $271 | $690 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
14 | $157 | $428 |
| Bladder biopsy using endoscope A procedure to remove a small tissue sample from the bladder using a thin, flexible tube with a camera. The sample is then examined to check for abnormalities. |
11 | $107 | $834 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
11 | $587 | $1,530 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
76.1% medium
23.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,984
Total received (2018-2024)
Avg $1,855/year across 7 years
Top 15% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
308
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,377 (64.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,608 (35.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,111
2023
$2,206
2022
$603
2021
$587
2020
$2,872
2019
$1,395
2018
$4,209
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Teleflex LLC
$247
Sumitomo Pharma America, Inc.
$181
ABBVIE INC.
$77
Olympus America Inc.
$69
Astellas Pharma US Inc
$59
Ferring Pharmaceuticals Inc.
$58
Myriad Genetic Laboratories, Inc.
$58
Laborie Medical Technologies Corp.
$55
COLOPLAST CORP
$49
Janssen Biotech, Inc.
$43
Dendreon Pharmaceuticals LLC
$34
Becton, Dickinson and Company
$30
Novartis Pharmaceuticals Corporation
$29
Tempus AI, Inc
$28
ACCORD HEALTHCARE, INC.
$25
KARL STORZ Endoscopy-America
$19
PFIZER INC.
$19
Verity Pharmaceuticals Inc.
$18
Merck Sharp & Dohme LLC
$15
Top 3 companies account for 45.4% of 2024 payments
All-time payments by company (2018-2024) ›
Bayer HealthCare Pharmaceuticals Inc.
$2,660
Avadel Specialty Pharmaceuticals, LLC
$2,039
Valencia Technologies Corporation
$861
Medtronic USA, Inc.
$746
Dendreon Pharmaceuticals LLC
$730
Astellas Pharma US Inc
$621
Ferring Pharmaceuticals Inc.
$570
Myriad Genetic Laboratories, Inc.
$522
Coloplast Corp
$454
TOLMAR Pharmaceuticals, Inc.
$407
Teleflex LLC
$395
Verity Pharmaceuticals Inc.
$270
Janssen Biotech, Inc.
$266
Sumitomo Pharma America, Inc.
$226
PFIZER INC.
$204
UroGen Pharma, Inc.
$184
NeoTract Inc.
$167
AbbVie, Inc.
$163
Olympus America Inc.
$142
PALETTE LIFE SCIENCES, INC.
$138
ABBVIE INC.
$128
Janssen Scientific Affairs, LLC
$95
Allergan Inc.
$90
Endo Pharmaceuticals Inc.
$79
Myovant Sciences Inc.
$65
Supernus Pharmaceuticals, Inc.
$64
UROVANT SCIENCES INC
$58
Laborie Medical Technologies Corp.
$55
COLOPLAST CORP
$49
Novartis Pharmaceuticals Corporation
$46
Palette Life Sciences, Inc.
$45
Janssen Pharmaceuticals, Inc
$44
Allergan, Inc.
$35
Merck Sharp & Dohme LLC
$32
Becton, Dickinson and Company
$30
Tempus AI, Inc
$28
AstraZeneca Pharmaceuticals LP
$27
Boston Scientific Corporation
$26
Pacira Pharmaceuticals Incorporated
$25
ACCORD HEALTHCARE, INC.
$25
Antares Pharma, Inc.
$23
NxThera, Inc.
$22
Bayer Healthcare Pharmaceuticals Inc.
$21
Accord Healthcare, Inc.
$20
KARL STORZ Endoscopy-America
$19
PROCEPT BioRobotics Corporation
$18
Tolmar, Inc.
$18
Celularity, Inc.
$12
Rochester Medical Corporation
$11
Blue Earth Diagnostics Limited
$11
Top 3 companies account for 42.8% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AFINITOR · AQUABEAM ROBOTIC SYSTEM · AVEED · Axumin · BOTOX · Bard Urinary Drainage Bag · Biovance · CAMCEVI · Coloplast TFL Drive · DARZALEX · ELIGARD · ERLEADA · Erleada · Exparel · FIRMAGON · GEMTESA · INTERSTIM · INTERSTIM ICON · JELMYTO · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LYNPARZA · Lupron · Lupron Depot · MYRBETRIQ · NOCDURNA · Noctiva · Nubeqa · ORGOVYX · Optilume BPH Drug Coated Balloon Catheter · PLUVICTO · PROLARIS · PROVENGE · Prolaris · Rezum · SOLESTA · SPACEOAR · SpeediCath · TITAN · Tlando · Trelstar · UROLIFT · UroLift · UroLift System · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · eCoin Device Kit · iTIND System · n.a.
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (64%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
18
Per 100K population
1.8
County median income
$71,434
Nearest hospital
SAINT AGNES MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Grewall is a mixed practice specialist, with above-average Medicare volume (top 7% in CA), with low-engagement industry engagement in the top 15% of CA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Grewall experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Grewall performed 7,740 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Grewall receive payments from pharmaceutical companies?
Yes. Dr. Grewall received a total of $12,984 from 50 companies across 308 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Grewall's costs compare to other urology physicians in Fresno?
Dr. Grewall's average Medicare payment per service is $28. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Grewall) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Fresno
Browse urology physicians in Fresno ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
By company
Avadel Specialty Pharmaceuticals, LLC Payments to Doctors
See all physicians who received payments from Avadel Specialty Pharmaceuticals, LLC.
By company
Valencia Technologies Corporation Payments to Doctors
See all physicians who received payments from Valencia Technologies Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology